ArticleOncoTargets and therapy2018

A retrospective examination of the US Food and Drug Administration's clinical pharmacology reviews of oncology biologics for potential use of therapeutic drug monitoring.

Brett Fleisher et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.